Scenarios that move RNAC

Cartesian Therapeutics, Inc. - Common Stock

Scenarios that move RNAC: 1 analysis, 0 positive, 1 negative.

  1. · Novartis acquires Abogen in $7.8B RNA therapeutics deal — ▼ · impact -33 · confidence low · horizon quarters

All scenarios · Run a scenario · Pricing